Silicon Laboratories Inc. — Form 10-Q Summary
Period: The filing covers the quarter ended October 2, 2010 and the nine months ended that date. The request metadata says “2009 Q3,” but the filing itself is for fiscal 2010 Q3.
Business context
Silicon Laboratories designs analog-intensive mixed-signal integrated circuits and operates as a fabless semiconductor company, relying on third parties for wafer fabrication, assembly and testing. Its products serve communications, consumer, industrial, automotive, medical and power-management markets. The company reported no individual end customer above 10% of nine-month revenue; distributors Edom Technology and Avnet represented 29% and 14%, respectively. Customers outside the United States generated 86% of nine-month revenue.
Financial performance
Amounts below are in millions of dollars, except per-share data and percentages.
| Metric | Q3 2010 | Q3 2009 | Nine months 2010 | Nine months 2009 |
|---|---|---|---|---|
| Revenue | $120.2 | $125.9 | $381.5 | $313.8 |
| Gross margin | $78.7 (65.5%) | $81.0 (64.4%) | $253.2 (66.4%) | $196.5 (62.6%) |
| Operating income | $19.3 (16.1%) | $26.5 (21.1%) | $75.7 (19.8%) | $40.4 (12.9%) |
| Net income | $18.2 | $22.4 | $60.4 | $32.8 |
| Diluted EPS | $0.40 | $0.47 | $1.28 | $0.71 |
| Operating cash flow | Not provided separately | Not provided separately | $83.5 | $78.2 |
Q3 revenue declined 4.6% year over year, with unit volume down 17.1%; average selling prices rose 15.0%. Management attributed the quarterly decline mainly to weaker demand for consumer-oriented products. Nine-month revenue increased 21.5%, reflecting stronger end markets and market-share gains; unit volume rose 14.8% and average selling prices rose 6.2%. Nine-month gross-margin improvement was attributed to product mix, inventory management and manufacturing cost reductions. Quarterly operating income and net income fell year over year, while nine-month earnings rose substantially.
Liquidity, balance sheet and capital allocation
- At October 2, 2010, cash and cash equivalents were $107.7 million, short-term investments $238.3 million and long-term investments $19.3 million. Management cited $346.0 million in cash, cash equivalents and short-term investments as principal liquidity.
- Current assets were $488.2 million and current liabilities $88.1 million. Total assets were $710.1 million; total liabilities were $109.7 million; stockholders’ equity was $600.4 million.
- The filing does not provide a clear, separately stated conventional debt balance. Interest expense was $0.1 million for the nine months. Long-term obligations and other liabilities totaled $21.7 million and include obligations such as derivative liabilities.
- Operating cash flow was $83.5 million. Investing activities used $48.3 million, including $18.4 million net cash for the Silicon Clocks acquisition. Financing activities used $123.3 million, principally reflecting $140.3 million of share repurchases. Cash and cash equivalents declined $88.1 million to $107.7 million.
- Accounts receivable increased to $63.8 million and inventory to $38.1 million from fiscal year-end. Management attributed inventory growth partly to actual demand falling short of forecasts; days sales outstanding rose to 48 from 40 and days of inventory to 83 from 65.
- The company repurchased 3.3 million shares for $140.3 million during the nine-month period. A July 2010 authorization permits up to $150 million of repurchases through 2011.
Outlook, commentary and risks
- For fiscal Q4 2010, management expected revenue of $105–$111 million and diluted EPS of $0.15–$0.21. It expected R&D expense to increase modestly in absolute dollars and SG&A to remain stable. Fiscal 2010 capital expenditures were expected to be approximately $12–$16 million.
- Management said existing cash and investment balances were sufficient for at least the next 12 months, while noting that acquisitions or other needs could lead it to seek additional financing.
- In April 2010, the company acquired Silicon Clocks for approximately $21.0 million in cash. The acquisition added MEMS timing technology and $9.5 million of in-process R&D; related products were not expected to contribute revenue before fiscal 2011. The purchase-price allocation was preliminary.
- All $19.9 million par value of auction-rate securities held had experienced failed auctions and was classified as long-term investment. Access to principal is uncertain and may be delayed until redemption, resale or maturity; management said it did not expect to need the funds before maturity and recorded no other-than-temporary impairment.
- Interest-rate swaps had a $4.7 million fair-value liability. Their agreements require at least $150 million of unencumbered cash and highly rated short-term investments or collateral may be required. No collateral had been posted. Management expected $2.6 million of swap losses to be reclassified into earnings over the next 12 months, offset by lower rent payments.
- The filing describes risks from semiconductor cyclicality, product and customer concentration, price erosion, forecast-driven inventory, long customer qualification and sales cycles, third-party manufacturing dependence, international operations and intellectual-property litigation. The IPO-related securities class action settlement had been approved, but appeals remained; the company could not predict the outcome if the settlement did not survive appeal.
- Management reported disclosure controls were effective as of October 2, 2010, with no material change in internal control over financial reporting during the quarter.
Important facts for investors to verify
- Confirm the reporting-period discrepancy: the filing is fiscal 2010 Q3, not 2009 Q3.
- Assess whether Q4 revenue and EPS guidance was achieved, particularly given Q3 consumer-demand weakness and the inventory build.
- Review the drivers and sustainability of nine-month revenue and margin growth, as well as the sharp year-over-year decline in Q3 operating income and EPS.
- Monitor distributor concentration, channel inventory and collection trends, including rising DSO and days of inventory.
- Verify the liquidity and recovery outlook for failed-auction auction-rate securities, and monitor compliance with the swaps’ $150 million liquidity/collateral covenant.
- Track the Silicon Clocks development milestones, remaining development costs and final purchase-price allocation, along with repurchase activity and the status of the securities-litigation appeals.